Drugs / Panolosetron
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01836705 Background | May → Nov 2013 | cancer | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Panolosetron | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01836705 ↗ |
| Route | Intravenous | “Route of administration: intravenous” NCT01836705 ↗ |